Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $706.5K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Starling Oncology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 1 insider, $261.1K in total
- Open-market sells
- 2 filings
- 2 insiders, $2.10M in total
- Insiders trading
- 3
- Net value
- −$1.84M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Starling Oncology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hively Brad | Director | 411,976 | Aug 24, 2026 | 4 |
| Chernett Jorey | 10% Owner | 10,660,858 | Aug 17, 2026 | 13 |
| Kaushal Mohit | Director | 205,716 | Jul 29, 2026 | 3 |
| McGeorge Anne | Director | 332,535 | Jul 29, 2026 | 2 |
| Pacala Mark L | Director | 286,881 | Jul 29, 2026 | 3 |
| Stolper Mark | Director | 56,957 | Jul 29, 2026 | 2 |
| Tzoumakas Kimberly Jo | Director | 46,301 | Jul 29, 2026 | 2 |
| Johnson Karen Marie | Director | 319,410 | Jul 29, 2026 | 2 |
| Podnos Yale | Chief Medical Officer | 259,527 | Jul 16, 2026 | 7 |
| Virnich Daniel | Chief Executive Officer | 2,337,166 | May 22, 2026 | 5 |
| Carter Robert Ross | Chief Financial Officer | 414,801 | May 22, 2026 | 5 |
| Langsam Jeffrey | Chief Clinical Officer | 127,650 | Apr 23, 2026 | 2 |
| England Kristin | Chief Administrative Officer | 153,780 | Apr 23, 2026 | 2 |
| Ling Gabriel | Director | 333,539 | Dec 1, 2025 | 3 |
| M33 Growth I L.P. | Director | 5,444,207 | Nov 20, 2025 | 1 |
| Toi M, LLC | Director | 5,444,207 | Nov 20, 2025 | 1 |
| M33 Growth I GP LLC | Director | 5,444,207 | Nov 20, 2025 | 1 |
| Barasch Richard A | Director | 2,635,881Indirect | Aug 14, 2025 | 0 |
| Castle Jeremy | Chief Operating Officer | 247,031 | May 22, 2025 | 0 |
| Havencrest Healthcare Partners, L.P. | 10% Owner | 252,626Indirect | Aug 20, 2024 | 0 |
| Toi HC I, LLC | 10% Owner | 252,626Indirect | Aug 20, 2024 | 0 |
| Havencrest Healthcare Partners GP, LLC | 10% Owner | 252,626Indirect | Aug 20, 2024 | 0 |
| Shah Mihir | Chief Financial Officer | 474,931 | May 23, 2024 | 0 |
| O'Meara Maeve | Director | 109,104 | Dec 28, 2023 | 0 |
| Sarin Ravi Yang | Director | 75,427 | Mar 21, 2023 | 0 |
| Miller Matthew P | Chief Operating Officer | 242,992 | Mar 21, 2023 | 0 |
| Simoneit Diona | Chief Accounting Officer | 29,318 | Nov 22, 2022 | 0 |
| Jimmy Holdings, Inc. | 10% Owner | 253,436Indirect | Jun 14, 2022 | 0 |
| Agajanian Richy | 10% Owner | 253,436Indirect | Jun 14, 2022 | 0 |
| Dalgleish Scott | Chief Financial Officer | 118,916 | Mar 29, 2022 | 0 |
| OncologyCare Partners, LLC | Director | 4,109,771Indirect | Nov 16, 2021 | 0 |
| Hochberg Steven | 10% Owner, Other: Possible Members of 10% Group | 40 | Nov 16, 2021 | 0 |
| Atinsky Lawrence | 10% Owner, Other: Possible Members of 10% Group | 40 | Nov 16, 2021 | 0 |
| DFP Sponsor LLC | 10% Owner, Other: Possible Members of 10% Group | 40 | Nov 16, 2021 | 0 |
| Deerfield Management Company, L.P. | 10% Owner, Other: Possible Members of 10% Group | 85,113Indirect | Nov 16, 2021 | 0 |
| Deerfield Mgmt L.P. | 10% Owner, Other: Possible Members of 10% Group | 85,113Indirect | Nov 16, 2021 | 0 |
| Deerfield Partners, L.P. | 10% Owner, Other: Possible Members of 10% Group | 85,113Indirect | Nov 16, 2021 | 0 |
| Flynn James E | 10% Owner, Other: Possible Members of 10% Group | 85,113Indirect | Nov 16, 2021 | 0 |
| Deerfield Private Design Fund IV, L.P. | 10% Owner, Other: Possible Members of 10% Group | 85,113Indirect | Nov 16, 2021 | 0 |
| Deerfield Mgmt IV, L.P. | 10% Owner, Other: Possible Members of 10% Group | 85,113Indirect | Nov 16, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:11 PM ET | Aug 21 | 3 days | Hively BradDirector | SSale | −298.9K | $6.51 | −$1.95M | −42.0%412.0K after | 10b5-1 |
| Aug 17, 2026 (view filing)10:13 AM ET | Aug 14 | 3 days | Chernett Jorey10% Owner | PPurchase | +12.0K | $6.54 | +$78.5K | +0.1%10.7M after | |
| Aug 17, 2026 (view filing)10:13 AM ET | Aug 13 | 4 days | Chernett Jorey10% Owner | SSale | −10.0K | $0.0624 | −$624 | –0 after | Derivative |
| Jul 22, 2026 (view filing)9:55 AM ET | Jul 21 | 1 day | Chernett Jorey10% Owner | PPurchase | +18.0K | $5.27 | +$94.9K | +0.2%10.6M after | |
| Jul 16, 2026 (view filing)8:05 PM ET | Jul 14 | 2 days | Podnos YaleChief Medical Officer | SSale | −23.5K | $6.41 | −$150.3K | −8.3%259.5K after | 2 lots10b5-1 |
| Jul 13, 2026 (view filing)11:34 AM ET | Jul 10 | 3 days | Chernett Jorey10% Owner | PPurchase | +15.0K | $5.85 | +$87.8K | +0.1%10.6M after | |
| Jun 24, 2026 (view filing) | Jun 23 | 1 day | Chernett Jorey10% Owner | PPurchase | +18.0K | $5.02 | +$90.4K | +0.2%10.6M after | |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Podnos YaleChief Medical Officer | SSale | −23.5K | $5.38 | −$126.2K | −8.3%259.5K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Chernett Jorey10% Owner | PPurchase | +12.0K | $4.75 | +$57.0K | +0.1%10.6M after | |
| May 21, 2026 (view filing) | May 19-20 | 2 days | Chernett Jorey10% Owner | PPurchase | +38.5K | $4.07 | +$156.6K | +0.4%10.6M after | 2 lots |
| May 20, 2026 (view filing) | May 19 | 1 day | Chernett Jorey10% Owner | PPurchase | +30.0K | $4.09 | +$122.7K | +0.3%10.5M after | |
| Apr 16, 2026 (view filing) | Apr 14-16 | 2 days | Kaushal MohitDirector | SSale | −95.7K | $3.50 | −$335.0K | −35.7%172.6K after | 2 lots10b5-1 |
| Apr 13, 2026 (view filing) | Apr 9 | 4 days | Chernett Jorey10% Owner | PPurchase | +20.0K | $3.10 | +$62.0K | +0.2%10.5M after | |
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Chernett Jorey10% Owner | PPurchase | +27.4K | $2.96 | +$81.2K | +0.3%10.5M after | |
| Mar 27, 2026 (view filing) | Mar 26 | 1 day | Chernett Jorey10% Owner | PPurchase | +50.0K | $3.15 | +$157.5K | +0.5%10.5M after | |
| Mar 25, 2026 (view filing) | Mar 24 | 1 day | Chernett Jorey10% Owner | PPurchase | +125.0K | $3.11 | +$388.8K | +1.2%10.4M after | |
| Mar 23, 2026 (view filing) | Mar 20 | 3 days | Chernett Jorey10% Owner | PPurchase | +25.0K | $3.35 | +$83.8K | +0.2%10.3M after | |
| Mar 17, 2026 (view filing) | Mar 13-17 | 4 days | Chernett Jorey10% Owner | PPurchase | +399.0K | $3.07 | +$1.23M | +4.0%10.3M after | 3 lots |
| Dec 16, 2025 (view filing) | Dec 15 | 1 day | Hively BradDirector | SSale | −13.3K | $3.77 | −$50.3K | −1.9%683.7K after | |
| Nov 20, 2025 (view filing) | Nov 18 | 2 days | Pacala Mark LDirector | SSale | −50.0K | $4.00 | −$200.0K | −22.2%175.0K after | 3 lots |
| Sep 5, 2025 (view filing)6:12 AM ET | Sep 4 | 1 day | M33 Growth I L.P. and 2 othersDirector, 10% Owner | SSale | −6.02M | $3.09 | −$18.6M | −43.1%7.93M after | |
| Sep 5, 2025 (view filing)6:12 AM ET | Sep 4 | 1 day | M33 Growth I L.P. and 2 othersDirector, 10% Owner | SSale | −681.8K | $3.09 | −$2.11M | −53.6%590.9K after | |
| Aug 21, 2025 (view filing) | Aug 19 | 2 days | Hively BradDirector | SSale | −20.2K | $4.06 | −$82.1K | −3.1%623.0K after | |
| Jun 9, 2025 (view filing)4:15 PM ET | Jun 5 | 4 days | M33 Growth I L.P. and 2 othersDirector, 10% Owner | SSale | −673.7K | $3.05 | −$2.05M | −4.6%14.0M after | |
| Jun 9, 2025 (view filing)4:15 PM ET | Jun 5 | 4 days | M33 Growth I L.P. and 2 othersDirector, 10% Owner | SSale | −76.3K | $3.05 | −$232.8K | −5.7%1.27M after | |
| Jun 5, 2025 (view filing)6:51 PM ET | Jun 3 | 2 days | Hively BradDirector | SSale | −1.98M | $2.87 | −$5.67M | −76.6%603.5K after | 2 lots |
| May 22, 2025 (view filing)7:38 PM ET | May 20 | 2 days | M33 Growth I L.P. and 2 othersDirector, 10% Owner | SSale | −1.80M | $2.71 | −$4.87M | −10.9%14.6M after | |
| May 22, 2025 (view filing)7:38 PM ET | May 20 | 2 days | M33 Growth I L.P. and 2 othersDirector, 10% Owner | SSale | −203.5K | $2.71 | −$552.2K | −13.1%1.35M after | |
| Apr 28, 2025 (view filing)7:20 PM ET | Mar 26 | 33 days | Hively BradDirector | PPurchase | +45.3K | $1.04 | +$47.2K | +6.8%712.0K after | Amended |
| Apr 28, 2025 (view filing)7:20 PM ET | Mar 26 | 33 days | Hively BradDirector | PPurchase | +22.6K | $0.125 | +$2.83K | –22.6K after | AmendedDerivative |
| Mar 28, 2025 (view filing)5:50 PM ET | Mar 26 | 2 days | Virnich DanielChief Executive Officer | PPurchase | +22.6K | $1.04 | +$23.6K | +3.2%724.4K after | |
| Mar 28, 2025 (view filing)5:50 PM ET | Mar 26 | 2 days | Virnich DanielChief Executive Officer | PPurchase | +11.3K | $0.125 | +$1.42K | –11.3K after | Derivative |
| Mar 28, 2025 (view filing)5:48 PM ET | Mar 26 | 2 days | Podnos YaleChief Medical Officer | PPurchase | +9.06K | $1.04 | +$9.43K | +12.9%79.0K after | |
| Mar 28, 2025 (view filing)5:48 PM ET | Mar 26 | 2 days | Podnos YaleChief Medical Officer | PPurchase | +4.53K | $0.125 | +$566 | –4.53K after | Derivative |
| Mar 28, 2025 (view filing)5:41 PM ET | Mar 26 | 2 days | Pacala Mark LDirector | PPurchase | +90.6K | $1.04 | +$94.3K | +67.4%225.0K after | |
| Mar 28, 2025 (view filing)5:41 PM ET | Mar 26 | 2 days | Pacala Mark LDirector | PPurchase | +42.3K | $0.125 | +$5.29K | –42.3K after | Derivative |
| Mar 28, 2025 (view filing)5:36 PM ET | Mar 26 | 2 days | Johnson Karen MarieDirector | PPurchase | +36.2K | $1.04 | +$37.7K | +21.7%203.4K after | |
| Mar 28, 2025 (view filing)5:36 PM ET | Mar 26 | 2 days | Johnson Karen MarieDirector | PPurchase | +18.1K | $0.125 | +$2.26K | –18.1K after | Derivative |
| Mar 28, 2025 (view filing)5:33 PM ET | Mar 26 | 2 days | Castle JeremyChief Operating Officer | PPurchase | +9.06K | $1.04 | +$9.43K | +11.1%90.4K after | |
| Mar 28, 2025 (view filing)5:33 PM ET | Mar 26 | 2 days | Castle JeremyChief Operating Officer | PPurchase | +4.53K | $0.125 | +$566 | –4.53K after | Derivative |
| Mar 28, 2025 (view filing)5:27 PM ET | Mar 26 | 2 days | Carter Robert RossChief Financial Officer | PPurchase | +9.06K | $1.04 | +$9.43K | +29.8%39.4K after | |
| Mar 28, 2025 (view filing)5:27 PM ET | Mar 26 | 2 days | Carter Robert RossChief Financial Officer | PPurchase | +4.53K | $0.125 | +$566 | –4.53K after | Derivative |
| Mar 28, 2025 (view filing)5:25 PM ET | Mar 26 | 2 days | Barasch Richard ADirector | PPurchase | +1.36M | $1.04 | +$1.42M | +325.6%1.78M after | |
| Mar 28, 2025 (view filing)5:25 PM ET | Mar 26 | 2 days | Barasch Richard ADirector | PPurchase | +679.2K | $0.125 | +$84.9K | –679.2K after | Derivative |
| Dec 2, 2024 (view filing)4:04 PM ET | Nov 26-Dec 2 | 6 daysLate | Hively BradDirector | PPurchase | +300.0K | $0.1667 | +$50.0K | +81.8%666.8K after | 2 lots |
| Jan 30, 2024 (view filing)7:07 PM ET | Jan 29 | 1 day | Havencrest Healthcare Partners, L.P. and 2 others10% Owner | SSale | −8.64K | $2.12 | −$18.3K | −100.0%0 after | |
| Jan 26, 2024 (view filing)7:19 PM ET | Jan 24-26 | 2 days | Havencrest Healthcare Partners, L.P. and 2 others10% Owner | SSale | −43.8K | $2.21 | −$96.8K | −83.5%8.64K after | 3 lots |
| Jan 23, 2024 (view filing)8:02 PM ET | Jan 19-23 | 4 days | Havencrest Healthcare Partners, L.P. and 2 others10% Owner | SSale | −27.6K | $2.12 | −$58.6K | −34.5%52.4K after | 3 lots |
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Shah MihirChief Financial Officer | PPurchase | +100.0K | $1.27 | +$127.0K | +43.8%328.1K after | 2 lots |
| Nov 21, 2023 (view filing) | Nov 17 | 4 days | Hively BradDirector | SSale | −25.0K | $2.24 | −$56.0K | −3.5%697.1K after |